Hematology: Basic Principles and Practice

Malignant Lymphomas in Childhood

Malignant lymphomas are the third most common malignancy among children and adolescents. Among children less than 15 years of age, non-Hodgkin Lymphoma (NHL) is more frequent; however, in patients up to 18 years of age, Hodgkin lymphoma (HL) is predominant.…

Virus-Associated Lymphoma

There are five well-characterized human viruses that are generally accepted as important in lymphomagenesis ( Table 87.1 ). These viruses may infect tumor cells (or their progenitors) or may act at a distance. The genomes of Epstein-Barr virus (EBV), Kaposi…

Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) is a distinct subtype of mature B-cell non-Hodgkin lymphoma (NHL) that accounts for 5% to 10% of all NHL. Although a subset of patients with MCL may have an indolent course, MCL is generally an aggressive…

High-Grade B-Cell Lymphomas

High-grade lymphomas are aggressive hematopoietic malignancies derived predominantly from transformed B cells. Notable subtypes include diffuse large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements (HGBCL), and Burkitt lymphoma (BL). Although these entities share many…

Marginal Zone Lymphomas (Extranodal/Malt, Splenic, and Nodal)

The term marginal zone refers to a histologic compartment located at the periphery of lymphoid follicles immediately outside their mantle zone. The marginal zone is especially evident in the spleen, although identical areas have been observed in other lymphoid structures,…

Origin of Non-Hodgkin Lymphoma and Therapeutic Targets

Over the past two decades, discoveries in basic immunology and the pathogenesis of malignancies have significantly advanced our understanding of the origin of lymphoid neoplasms. These diseases have been reexamined and grouped based on recurrent chromosomal rearrangements, histologic patterns, gene…

Hodgkin Lymphoma

Hodgkin lymphoma (HL) is an uncommon lymphoproliferative malignancy arising from B cells. It can affect all age groups but is most common in young adults. HL is the first adult malignancy to demonstrate the curative potential of combination chemotherapy. Today,…

Origin of Hodgkin Lymphoma and Therapeutic Targets

More than 150 years ago, Thomas Hodgkin described several cases of a lymphoproliferative disease, later named Hodgkin disease. For a long time this malignancy, now called Hodgkin lymphoma (HL), has been one of the most enigmatic forms of lymphomas. This…